The Pros and Cons of Ozempic: A Comprehensive Guide.

Medicare Part D covers Ozempic, a medication used to treat Type 2 diabetes, but not for weight loss. Medicare does not cover any prescription drugs for weight loss, including Wegovy, a weight loss drug that uses the same active ingredient as Ozempic. Medicare beneficiaries interested in Ozempic should check their plan's formulary to confirm coverage. The estimated cost to cover Wegovy for Medicare Part D would be about $26.8 billion per year, making it a costly policy change.